Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 261

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 261
---
 |    - |
| Forfeited                           |     |                  |         - |     |                                     |    - |     |                                         |    - |
| Outstanding as of December 31, 2024 |     |                  | 1,359,375 |     | $                                   | 0.80 |     |                                         | 0.93 |

| F-19 |

JUPITER NEUROSCIENCES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2024 and 2023

Note 6 – Stockholders’ Equity (Deficit), continued

Restricted Stock Units

On September 29, 2023, the Company issued an aggregate of 1,399,834restricted stock units with a grant date value of $ 1.33per unit in exchange for the forgiveness of accrued compensation. Pursuant to the amendment dated December 18, 2023, the restricted stock units shall vest on the on earlier event of either the occurrence of an initial public offering or in the event of change of control of the Company. The restricted stock units have an aggregate grant date fair value of $ 1,866,445.

On December 18, 2023, the Company terminated 1,399,384restricted stock units and issued an aggregate of 1,618,537restricted stock units with a grant date value of $ 1.33in exchange for the forgiveness of accrued compensation. The restricted stock units shall vest on the earlier event of either the expiration of the lock-up period by the underwriters after the initial public offering or in the event of change of control of the Company. The restricted stock units have an aggregate grant date fair value of $ 2,158,050.

On March 15, 2024, the Company issued 7,500restricted stock units with a grant date value of $ 1.33per unit in exchange for the forgiveness of accrued compensation. The restricted stock units shall vest on the earlier event of either the expiration of the lock-up period by the underwriters after the initial public offering or in the event of change of control of the Company.

As of December 31, 2024, the Company had an aggregate of 1,626,037restricted stock units outstanding with an aggregate fair value of $ 2,195,550.

Note 7 – Income Taxes

A reconciliation of income taxes at the U.S. federal statutory rate to the benefit for income taxes is as follows:

Schedule of Income Tax Provision